Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
MAIA Biotechnology, Inc. (MAIA) had Weighted-Average Shares Outstanding (Diluted) of 22.20M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-23.25M |
|
-- |
|
-- |
|
$16.96M |
|
$-16.96M |
|
$-6.30M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-16.96M |
|
$-16.96M |
|
22.20M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
22.20M |
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$10.15M |
|
-- |
|
$0.00M |
|
$10.16M |
|
$3.83M |
|
-- |
|
$2.69M |
|
$6.52M |
|
$3.63M |
|
$3.63M |
|
$3.63M |
|
26.16M |
|
| Cash Flow Statement Financials | |
$-15.70M |
|
-- |
|
$18.18M |
|
$7.15M |
|
$9.60M |
|
$2.45M |
|
$1.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-639.81% |
|
-639.81% |
|
-228.99% |
|
-639.81% |
|
$0.14 |
|
$-0.71 |
|
$-0.71 |
|